Clinical trial
Organ Preservation in Patients With a Good Clinical Response After (Chemo)Radiation for Rectal Cancer: Defining the Role of Additional Contact X-ray Brachytherapy Versus Extending the Waiting Interval and Local Excision
NCT05772923 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Organ Preservation in Patients With a Good Clinical Response After (Chemo)Radiation for Rectal Cancer: Defining the Role of Additional Contact X-ray Brachytherapy Versus Extending the Waiting Interval and Local Excision
- Lead sponsor
- The Netherlands Cancer Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 16, 2021
- Completion date
- March 31, 2029
- Enrollment
- 168 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced rectal carcinoma, organ preservation, quality of life, rectal cancer